Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies

OBJECTIVE: Anti-Hu antibodies (Hu-Ab) and anti-CV2/CRMP5 antibodies (CV2/CRMP5-Ab) have been identified in association with paraneoplastic neurological disorders. However, it is not clear whether these antibodies are associated with specific neurological symptoms or are only markers of anti-cancer i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Honnorat, Jérôme, Cartalat-Carel, Stéphanie, Ricard, Damien, Camdessanche, Jean-Philippe, Carpentier, Antoine F., Rogemond, Véronique, Chapuis, François, Aguera, Michèle, Decullier, Evelyne, Duchemin, Anne-Marie, Graus, Francesc, Antoine, Jean-Christophe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BMJ Group 2009
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2664637/
https://ncbi.nlm.nih.gov/pubmed/18931014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.2007.138016
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg